Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
3.820
+0.010 (0.26%)
At close: Aug 14, 2025, 4:00 PM
3.820
0.00 (0.00%)
After-hours: Aug 14, 2025, 4:10 PM EDT
Evotec SE Market Cap
Evotec SE has a market cap or net worth of $1.35 billion as of August 14, 2025. Its market cap has decreased by -16.93% in one year.
Market Cap
1.35B
Enterprise Value
1.48B
1-Year Change
-16.93%
Ranking
Category
Stock Price
$3.82
Market Cap Chart
Since the IPO on November 2, 2010, Evotec SE's market cap has increased from $366.30M to $1.35B, an increase of 267.75%. That is a compound annual growth rate of 9.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 1.34B | -11.26% |
| Dec 30, 2024 | 1.51B | -63.78% |
| Dec 29, 2023 | 4.16B | 44.42% |
| Dec 30, 2022 | 2.88B | -65.81% |
| Dec 30, 2021 | 8.43B | 38.57% |
| Dec 30, 2020 | 6.08B | 56.16% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |